Literature DB >> 7775449

Ligand-dependent antagonism by retinoid X receptors of inhibitory thyroid hormone response elements.

O Cohen1, T R Flynn, F E Wondisford.   

Abstract

The role of retinoid X receptors (RXRs) on negative thyroid hormone response elements (nTREs) is not well understood. In this report, we demonstrate that an orientation-specific monomeric thyroid hormone receptor (T3R) DNA-binding site mediates thyroid hormone inhibition in the thyrotropin beta subunit gene (TSH-beta) from human and murine species. Unlike positive TREs, addition of the ligand 9-cis retinoic acid (9-cis RA) to cells transfected with a T3R beta 1 expression vector significantly reduces thyroid hormone inhibition of the TSH-beta gene, indicating that endogenous retinoid receptors antagonize T3R function. Cotransfection of an RXR-alpha but not a retinoic acid receptor-alpha expression vector further antagonizes thyroid hormone inhibition, but only in the presence of 9-cis RA. Antagonism by RXR requires both an intact DNA- and ligand-binding domain. Removal of monomeric T3R binding to the TSH-beta nTRE also requires both RXR domains. A model is proposed whereby monomeric T3R is removed from a nTRE by RXR occupied by its ligand 9-cis RA. This is the first report of 9-cis RA-dependent antagonism of thyroid hormone inhibition via negative TREs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775449     DOI: 10.1074/jbc.270.23.13899

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Thyroid-hormone-dependent negative regulation of thyrotropin beta gene by thyroid hormone receptors: study with a new experimental system using CV1 cells.

Authors:  Keiko Nakano; Akio Matsushita; Shigekazu Sasaki; Hiroko Misawa; Kozo Nishiyama; Yumiko Kashiwabara; Hirotoshi Nakamura
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

2.  Fundamentally distinct roles of thyroid hormone receptor isoforms in a thyrotroph cell line are due to differential DNA binding.

Authors:  Maria I Chiamolera; Aniket R Sidhaye; Shunichi Matsumoto; Qiyi He; Koshi Hashimoto; Tania M Ortiga-Carvalho; Fredric E Wondisford
Journal:  Mol Endocrinol       Date:  2012-05-08

3.  Mediator subunit MED1 is a T3-dependent and T3-independent coactivator on the thyrotropin β gene promoter.

Authors:  Keiji Matsui; Kasumi Oda; Shumpei Mizuta; Ruri Ishino; Norinaga Urahama; Natsumi Hasegawa; Robert G Roeder; Mitsuhiro Ito
Journal:  Biochem Biophys Res Commun       Date:  2013-09-18       Impact factor: 3.575

4.  Divergent roles for thyroid hormone receptor beta isoforms in the endocrine axis and auditory system.

Authors:  E D Abel; M E Boers; C Pazos-Moura; E Moura; H Kaulbach; M Zakaria; B Lowell; S Radovick; M C Liberman; F Wondisford
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

5.  Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface.

Authors:  Tania M Ortiga-Carvalho; Nobuyuki Shibusawa; Amisra Nikrodhanond; Karen J Oliveira; Danielle S Machado; Xiao-Hui Liao; Ronald N Cohen; Samuel Refetoff; Fredric E Wondisford
Journal:  J Clin Invest       Date:  2005-08-11       Impact factor: 14.808

6.  Dissecting the Relation between a nuclear receptor and GATA: binding affinity studies of thyroid hormone receptor and GATA2 on TSHβ promoter.

Authors:  Ana Carolina Migliorini Figueira; Igor Polikarpov; Dmitry Veprintsev; Guilherme Martins Santos
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

7.  Novel insight from transgenic mice into thyroid hormone resistance and the regulation of thyrotropin.

Authors:  E D Abel; H C Kaulbach; A Campos-Barros; R S Ahima; M E Boers; K Hashimoto; D Forrest; F E Wondisford
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

8.  Liganded thyroid hormone receptor inhibits phorbol 12-O-tetradecanoate-13-acetate-induced enhancer activity via firefly luciferase cDNA.

Authors:  Hiroko Misawa; Shigekazu Sasaki; Akio Matsushita; Kenji Ohba; Hiroyuki Iwaki; Hideyuki Matsunaga; Shingo Suzuki; Keiko Ishizuka; Yutaka Oki; Hirotoshi Nakamura
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.